2 Dividend Stocks to Buy Hand Over Fist in November was originally published by The Motley Fool Their recent issues are nothing to fret over for investors focused on the long game. Avidity Biosciences expands its pipeline to include two new drugs targeting rare genetic cardiomyopathies.

Here are two brilliant options along those lines: CVS Health ( CVS 0.44%) and Bristol Myers Squibb ( BMY -1.03%). Find out why, despite the issues they've faced, both of these healthcare dividend stocks are attractive to investors focused on the long game.

In an unpredictable market, finding reliable dividend growth is a challenge. Find out 3 stocks that offer standout value and growth potential.

As oil prices remain volatile around thelatest OPEC+ moves and ongoing demand concerns, all eyes are on the energy sector, especially as investors consider President-elect Trump’s energy policies. While deregulation could favor the energy sector,

One stock yields 6% today. Another has grown its dividend by 460% over the past decade. Both are blue chip bargains to buy right now.